Biotech · Public company · Charlotte, NC, US

Adaptin Bio, Inc.

Ticker APTN · SEC CIK 0001938571

Track this companyFree. Adds Adaptin Bio, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

SEC filings12

S-1 · REGISTRATION STATEMENTSEC EDGAR · filed Aug 28, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Aug 25, 2026 · fetched Nov 12, 2026
10-Q · QUARTERLY REPORTSEC EDGAR · filed Aug 13, 2026 · fetched Nov 12, 2026
10-K/A · AMENDMENT NO. 1 TO FORM 10-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
10-Q · QUARTERLY REPORTSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Apr 6, 2026 · fetched Nov 12, 2026
10-K · ANNUAL REPORTSEC EDGAR · filed Apr 1, 2026 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Dec 23, 2025 · fetched Nov 12, 2026
10-Q · QUARTERLY REPORTSEC EDGAR · filed Nov 14, 2025 · fetched Nov 12, 2026
8-K · CURRENT REPORTSEC EDGAR · filed Oct 6, 2025 · fetched Nov 12, 2026
10-Q · QUARTERLY REPORTSEC EDGAR · filed Aug 14, 2025 · fetched Nov 12, 2026
S-1/A · AMENDMENT NO. 2 TO FORM S-1SEC EDGAR · filed Jul 28, 2025 · fetched Nov 12, 2026